With the rapid growth in science and technology, there has been a marked growth in emerging technologies. Various technologies have flooded the market in every field. Mitochondrial Replacement Therapy(MRT) is one such technology in the field of biotechnology that has the potential to change the very dynamics of newly emerging reproductive technology. One in 5,000 individuals has a genetic mitochondrial disease. The increasing prevalence of mitochondrial disorders resulting in significant morbidity and mortality combined with the higher potential of genetic transmission to the next generation are the factors that are expected to drive the market growth for such therapies. Many countries are in line to legalise such therapies. However, ethical concerns remain which need to be looked into to make this therapy legal.